Anthology
PrivateLast Round
Seed
Mar 20, 2026
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Anthology is a biotechnology company that develops a genome evolution technology designed to scale biomanufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anthology Comparables
Compare Anthology with similar companies based on industry and business-model similarity.
Anthology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 20, 2026 | ||||
| Grant | Dec 20, 2024 | ||||
| Seed | Dec 14, 2023 |
Anthology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dolby Family Ventures | Seed |
| Engine Ventures | Seed |
| Climate Capital | Seed |
| BoxOne Ventures | Seed |
| Defense Advanced Research Projects Agency | Grant |
| Alumni Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 10, 2026
Open roles increased to 13, 65% of headcount.
- Jul 20, 2026
Open roles increased to 11, 55% of headcount.
Anthology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Anthology's valuation, stock price, and market status.